nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—MPO—Carboplatin—ocular cancer	0.796	1	CbGbCtD
Mesalazine—IKBKB—B Cell Receptor Signaling Pathway—HRAS—ocular cancer	0.000208	0.00102	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—CDKN1A—ocular cancer	0.000207	0.00101	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis—AKT1—ocular cancer	0.000206	0.00101	CbGpPWpGaD
Mesalazine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—AKT1—ocular cancer	0.000206	0.00101	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000206	0.00101	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.000205	0.001	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000205	0.001	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PSPH—ocular cancer	0.000205	0.001	CbGpPWpGaD
Mesalazine—CHUK—B Cell Receptor Signaling Pathway—AKT1—ocular cancer	0.000203	0.000992	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—CDKN1A—ocular cancer	0.000202	0.000987	CbGpPWpGaD
Mesalazine—CHUK—PI-3K cascade—AKT1—ocular cancer	0.000201	0.000984	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—EP300—ocular cancer	0.0002	0.000977	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—CDKN1B—ocular cancer	0.000198	0.00097	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—CDKN1A—ocular cancer	0.000198	0.000967	CbGpPWpGaD
Mesalazine—CHUK—PI3K/AKT activation—AKT1—ocular cancer	0.000196	0.000961	CbGpPWpGaD
Mesalazine—IKBKB—TCR Signaling Pathway—AKT1—ocular cancer	0.000195	0.000955	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000195	0.000955	CbGpPWpGaD
Mesalazine—CHUK—Toll-like Receptor Signaling Pathway—AKT1—ocular cancer	0.000195	0.000953	CbGpPWpGaD
Mesalazine—CHUK—GAB1 signalosome—AKT1—ocular cancer	0.000195	0.000953	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000195	0.000952	CbGpPWpGaD
Mesalazine—PTGS2—C-MYB transcription factor network—MYC—ocular cancer	0.000194	0.000951	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—CDKN1B—ocular cancer	0.000194	0.000947	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—CDKN1A—ocular cancer	0.000193	0.000945	CbGpPWpGaD
Mesalazine—IKBKB—TNF alpha Signaling Pathway—AKT1—ocular cancer	0.000192	0.000939	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SAG—ocular cancer	0.000191	0.000936	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by Interleukins—HRAS—ocular cancer	0.000191	0.000935	CbGpPWpGaD
Mesalazine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—ocular cancer	0.00019	0.000931	CbGpPWpGaD
Mesalazine—CHUK—Disease—TFDP1—ocular cancer	0.000187	0.000916	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—GNA11—ocular cancer	0.000187	0.000915	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—CCND1—ocular cancer	0.000185	0.000903	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Receptor Signaling Pathway—AKT1—ocular cancer	0.000184	0.0009	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—CDKN1A—ocular cancer	0.000183	0.000895	CbGpPWpGaD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—AKT1—ocular cancer	0.000177	0.000864	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—MDM2—ocular cancer	0.000176	0.000862	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—GNAQ—ocular cancer	0.000174	0.00085	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SAG—ocular cancer	0.000173	0.000848	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—MYC—ocular cancer	0.000171	0.000836	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—MAML2—ocular cancer	0.000171	0.000835	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TGFB1—ocular cancer	0.000171	0.000834	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—HRAS—ocular cancer	0.00017	0.000833	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00017	0.000832	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.00017	0.00083	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—E2F5—ocular cancer	0.000169	0.000828	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.000169	0.000825	CbGpPWpGaD
Mesalazine—CHUK—BDNF signaling pathway—HRAS—ocular cancer	0.000167	0.000819	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—E2F4—ocular cancer	0.000166	0.000811	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—CDK4—ocular cancer	0.000164	0.0008	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—HRAS—ocular cancer	0.000163	0.000797	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—RBL1—ocular cancer	0.000163	0.000796	CbGpPWpGaD
Mesalazine—PTGS2—Disease—SAG—ocular cancer	0.000162	0.000791	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—CDKN1B—ocular cancer	0.000161	0.000787	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—HRAS—ocular cancer	0.00016	0.000785	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—MDM2—ocular cancer	0.00016	0.000782	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—E2F5—ocular cancer	0.000153	0.000751	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—HRAS—ocular cancer	0.000153	0.000749	CbGpPWpGaD
Mesalazine—PTGS2—C-MYB transcription factor network—HRAS—ocular cancer	0.000153	0.000747	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—HRAS—ocular cancer	0.000152	0.000746	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—AKT1—ocular cancer	0.000152	0.000744	CbGpPWpGaD
Mesalazine—IKBKB—BDNF signaling pathway—HRAS—ocular cancer	0.000152	0.000743	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—HRAS—ocular cancer	0.000152	0.000742	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—HRAS—ocular cancer	0.000151	0.000738	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—AKT1—ocular cancer	0.00015	0.000736	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—E2F4—ocular cancer	0.00015	0.000736	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—ocular cancer	0.000149	0.000728	CbGpPWpGaD
Mesalazine—CHUK—Disease—MAML2—ocular cancer	0.000149	0.000727	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—CDKN1A—ocular cancer	0.000149	0.000727	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—MYC—ocular cancer	0.000148	0.000725	CbGpPWpGaD
Mesalazine—CHUK—BDNF signaling pathway—AKT1—ocular cancer	0.000148	0.000723	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TGFB1—ocular cancer	0.000148	0.000723	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—RBL1—ocular cancer	0.000147	0.000721	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—CDKN1B—ocular cancer	0.000146	0.000714	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000144	0.000706	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—AKT1—ocular cancer	0.000144	0.000704	CbGpPWpGaD
Mesalazine—PTGS2—Disease—E2F5—ocular cancer	0.000143	0.0007	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—TP53—ocular cancer	0.000143	0.000699	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.000142	0.000696	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—ocular cancer	0.000142	0.000695	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—HRAS—ocular cancer	0.000142	0.000695	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—HRAS—ocular cancer	0.000142	0.000695	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—AKT1—ocular cancer	0.000142	0.000693	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—E2F3—ocular cancer	0.000141	0.00069	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—HRAS—ocular cancer	0.000141	0.000688	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TP53—ocular cancer	0.00014	0.000687	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.00014	0.000686	CbGpPWpGaD
Mesalazine—PTGS2—Disease—E2F4—ocular cancer	0.00014	0.000686	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.00014	0.000683	CbGpPWpGaD
Mesalazine—IKBKB—Insulin Signaling—HRAS—ocular cancer	0.00014	0.000683	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—HRAS—ocular cancer	0.000139	0.000682	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—HRAS—ocular cancer	0.000139	0.000679	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—ocular cancer	0.000138	0.000675	CbGpPWpGaD
Mesalazine—PTGS2—Disease—RBL1—ocular cancer	0.000138	0.000673	CbGpPWpGaD
Mesalazine—PTGS2—Disease—RPL39—ocular cancer	0.000138	0.000673	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—AKT1—ocular cancer	0.000135	0.000662	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—ocular cancer	0.000135	0.00066	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—CDKN1A—ocular cancer	0.000135	0.000659	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—AKT1—ocular cancer	0.000135	0.000658	CbGpPWpGaD
Mesalazine—IKBKB—BDNF signaling pathway—AKT1—ocular cancer	0.000134	0.000656	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—AKT1—ocular cancer	0.000134	0.000655	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—AKT1—ocular cancer	0.000133	0.000652	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000132	0.000644	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—HRAS—ocular cancer	0.000131	0.000643	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—ocular cancer	0.000131	0.000643	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TFDP1—ocular cancer	0.000131	0.000641	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—ocular cancer	0.000129	0.00063	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—E2F3—ocular cancer	0.000128	0.000625	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	0.000126	0.000615	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000126	0.000615	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—AKT1—ocular cancer	0.000125	0.000613	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—AKT1—ocular cancer	0.000125	0.000613	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—AKT1—ocular cancer	0.000125	0.000613	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—HDAC1—ocular cancer	0.000125	0.00061	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—AKT1—ocular cancer	0.000124	0.000608	CbGpPWpGaD
Mesalazine—IKBKB—Insulin Signaling—AKT1—ocular cancer	0.000123	0.000603	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—AKT1—ocular cancer	0.000123	0.000602	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—AKT1—ocular cancer	0.000123	0.0006	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TP53—ocular cancer	0.000122	0.000595	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000122	0.000595	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—HRAS—ocular cancer	0.000119	0.000583	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—ocular cancer	0.000119	0.000583	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TFDP1—ocular cancer	0.000119	0.000581	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—AKT1—ocular cancer	0.000119	0.00058	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000118	0.000577	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—AKT1—ocular cancer	0.000116	0.000568	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GNA11—ocular cancer	0.000116	0.000566	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000116	0.000566	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—ocular cancer	0.000114	0.000556	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—CDKN2B—ocular cancer	0.000112	0.000547	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	0.000111	0.000543	CbGpPWpGaD
Mesalazine—PTGS2—Disease—TFDP1—ocular cancer	0.000111	0.000542	CbGpPWpGaD
Mesalazine—CHUK—Disease—HDAC1—ocular cancer	0.000109	0.000532	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GNAQ—ocular cancer	0.000108	0.000526	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—AKT1—ocular cancer	0.000105	0.000515	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MAML2—ocular cancer	0.000104	0.000509	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000101	0.000493	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—MDM2—ocular cancer	0.000101	0.000492	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000101	0.000492	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—HRAS—ocular cancer	9.84e-05	0.000481	CbGpPWpGaD
Mesalazine—CHUK—Disease—CDKN2B—ocular cancer	9.75e-05	0.000477	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—EP300—ocular cancer	9.72e-05	0.000476	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—HRAS—ocular cancer	9.67e-05	0.000473	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—MDM2—ocular cancer	9.65e-05	0.000472	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MAML2—ocular cancer	9.44e-05	0.000462	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CDKN1B—ocular cancer	9.18e-05	0.000449	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—MDM2—ocular cancer	9.12e-05	0.000446	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GNA11—ocular cancer	9.09e-05	0.000444	CbGpPWpGaD
Mesalazine—PPARG—Generic Transcription Pathway—MYC—ocular cancer	9e-05	0.00044	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—HRAS—ocular cancer	8.92e-05	0.000436	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CDKN1B—ocular cancer	8.82e-05	0.000431	CbGpPWpGaD
Mesalazine—PTGS2—Disease—MAML2—ocular cancer	8.81e-05	0.000431	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—HRAS—ocular cancer	8.77e-05	0.000429	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—MDM2—ocular cancer	8.75e-05	0.000428	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—EP300—ocular cancer	8.68e-05	0.000425	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—AKT1—ocular cancer	8.54e-05	0.000418	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CDKN1A—ocular cancer	8.47e-05	0.000414	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TGFB1—ocular cancer	8.45e-05	0.000413	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GNAQ—ocular cancer	8.45e-05	0.000413	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CDKN1B—ocular cancer	8.32e-05	0.000407	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	8.28e-05	0.000405	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GNA11—ocular cancer	8.24e-05	0.000403	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CDKN1A—ocular cancer	8.14e-05	0.000398	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GNA11—ocular cancer	8.11e-05	0.000397	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—EP300—ocular cancer	8.06e-05	0.000394	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CDKN1B—ocular cancer	7.99e-05	0.000391	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—AKT1—ocular cancer	7.74e-05	0.000379	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CDKN1A—ocular cancer	7.68e-05	0.000376	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GNAQ—ocular cancer	7.66e-05	0.000375	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HDAC1—ocular cancer	7.61e-05	0.000372	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GNAQ—ocular cancer	7.54e-05	0.000369	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CDKN1A—ocular cancer	7.38e-05	0.000361	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—EP300—ocular cancer	7.31e-05	0.000358	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	6.99e-05	0.000342	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HDAC1—ocular cancer	6.9e-05	0.000338	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CDKN2B—ocular cancer	6.83e-05	0.000334	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—HRAS—ocular cancer	6.65e-05	0.000326	CbGpPWpGaD
Mesalazine—PTGS2—Disease—HDAC1—ocular cancer	6.44e-05	0.000315	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GNA11—ocular cancer	6.44e-05	0.000315	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—E2F1—ocular cancer	6.26e-05	0.000306	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—EP300—ocular cancer	6.25e-05	0.000306	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CDKN2B—ocular cancer	6.19e-05	0.000303	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	6.08e-05	0.000298	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GNAQ—ocular cancer	5.98e-05	0.000293	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—AKT1—ocular cancer	5.88e-05	0.000287	CbGpPWpGaD
Mesalazine—CHUK—Immune System—MDM2—ocular cancer	5.86e-05	0.000286	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CDKN2B—ocular cancer	5.77e-05	0.000282	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—E2F1—ocular cancer	5.68e-05	0.000278	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—HRAS—ocular cancer	5.52e-05	0.00027	CbGpPWpGaD
Mesalazine—CHUK—Disease—MDM2—ocular cancer	5.41e-05	0.000264	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CDKN1B—ocular cancer	5.35e-05	0.000262	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—MDM2—ocular cancer	5.31e-05	0.00026	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—HRAS—ocular cancer	5.3e-05	0.000259	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—HRAS—ocular cancer	5e-05	0.000245	CbGpPWpGaD
Mesalazine—CHUK—Disease—CDKN1B—ocular cancer	4.94e-05	0.000241	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CDKN1A—ocular cancer	4.93e-05	0.000241	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—AKT1—ocular cancer	4.87e-05	0.000238	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CDKN1B—ocular cancer	4.85e-05	0.000237	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	4.83e-05	0.000236	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—HRAS—ocular cancer	4.8e-05	0.000235	CbGpPWpGaD
Mesalazine—CHUK—Immune System—EP300—ocular cancer	4.7e-05	0.00023	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—AKT1—ocular cancer	4.68e-05	0.000229	CbGpPWpGaD
Mesalazine—CHUK—Disease—CDKN1A—ocular cancer	4.56e-05	0.000223	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CDKN1A—ocular cancer	4.47e-05	0.000219	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—AKT1—ocular cancer	4.42e-05	0.000216	CbGpPWpGaD
Mesalazine—CHUK—Disease—EP300—ocular cancer	4.33e-05	0.000212	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—MYC—ocular cancer	4.33e-05	0.000212	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—EP300—ocular cancer	4.26e-05	0.000208	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—AKT1—ocular cancer	4.24e-05	0.000208	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—EP300—ocular cancer	3.87e-05	0.000189	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MDM2—ocular cancer	3.79e-05	0.000185	CbGpPWpGaD
Mesalazine—CHUK—Disease—MYC—ocular cancer	3.78e-05	0.000185	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—AKT1—ocular cancer	3.78e-05	0.000185	CbGpPWpGaD
Mesalazine—CHUK—Disease—TGFB1—ocular cancer	3.77e-05	0.000184	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CDKN1B—ocular cancer	3.46e-05	0.000169	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MDM2—ocular cancer	3.43e-05	0.000168	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCND1—ocular cancer	3.3e-05	0.000161	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HRAS—ocular cancer	3.21e-05	0.000157	CbGpPWpGaD
Mesalazine—PTGS2—Disease—MDM2—ocular cancer	3.2e-05	0.000157	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CDKN1A—ocular cancer	3.19e-05	0.000156	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CDKN1B—ocular cancer	3.13e-05	0.000153	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—EP300—ocular cancer	3.04e-05	0.000149	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—AKT1—ocular cancer	3.01e-05	0.000147	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCND1—ocular cancer	2.99e-05	0.000146	CbGpPWpGaD
Mesalazine—CHUK—Disease—HRAS—ocular cancer	2.97e-05	0.000145	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CDKN1B—ocular cancer	2.92e-05	0.000143	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HRAS—ocular cancer	2.91e-05	0.000143	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CDKN1A—ocular cancer	2.89e-05	0.000142	CbGpPWpGaD
Mesalazine—CHUK—Immune System—AKT1—ocular cancer	2.84e-05	0.000139	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—EP300—ocular cancer	2.75e-05	0.000135	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—EP300—ocular cancer	2.71e-05	0.000133	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CDKN1A—ocular cancer	2.7e-05	0.000132	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MYC—ocular cancer	2.65e-05	0.000129	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TGFB1—ocular cancer	2.64e-05	0.000129	CbGpPWpGaD
Mesalazine—CHUK—Disease—AKT1—ocular cancer	2.62e-05	0.000128	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—AKT1—ocular cancer	2.57e-05	0.000126	CbGpPWpGaD
Mesalazine—PTGS2—Disease—EP300—ocular cancer	2.57e-05	0.000126	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MYC—ocular cancer	2.4e-05	0.000117	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TGFB1—ocular cancer	2.39e-05	0.000117	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—AKT1—ocular cancer	2.34e-05	0.000114	CbGpPWpGaD
Mesalazine—PTGS2—Disease—MYC—ocular cancer	2.24e-05	0.000109	CbGpPWpGaD
Mesalazine—PTGS2—Disease—TGFB1—ocular cancer	2.23e-05	0.000109	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TP53—ocular cancer	2.17e-05	0.000106	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—EP300—ocular cancer	2.15e-05	0.000105	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HRAS—ocular cancer	2.08e-05	0.000102	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TP53—ocular cancer	1.97e-05	9.64e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HRAS—ocular cancer	1.88e-05	9.22e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—AKT1—ocular cancer	1.83e-05	8.97e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—HRAS—ocular cancer	1.76e-05	8.6e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—AKT1—ocular cancer	1.66e-05	8.14e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—AKT1—ocular cancer	1.64e-05	8.01e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—AKT1—ocular cancer	1.55e-05	7.59e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—AKT1—ocular cancer	1.3e-05	6.36e-05	CbGpPWpGaD
